Osterweis Capital Management Inc Procept Bio Robotics Corp Transaction History
Osterweis Capital Management Inc
- $1.55 Billion
- Q2 2024
A detailed history of Osterweis Capital Management Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Osterweis Capital Management Inc holds 172,345 shares of PRCT stock, worth $12.8 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
172,345
Previous 104,155
65.47%
Holding current value
$12.8 Million
Previous $5.15 Million
104.55%
% of portfolio
0.68%
Previous 0.35%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
214Shares Held
36.3MCall Options Held
251KPut Options Held
101K-
Vanguard Group Inc Valley Forge, PA4.71MShares$350 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$259 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.81MShares$134 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.75MShares$130 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.37MShares$101 Million0.53% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.31B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...